Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 544 results for "adap"

Adaptimmune Announces Initiation of Myxoid/Round Cell Liposarcoma Study
EuroInvestor

ADAPTIMMUNE THERAPEUTICS PLC (NASDAQ:ADAP) Files An 8-K Regula...

Item7.01 Other Events. On December5, 2016, Adaptimmune Therapeutics plc (the Company) issued a press release announcing that it has initiated a study of its NY-ESO SPEAR T-cells in myxoid/round cell liposarcoma (MRCLS). Patient screening is ... 4 Traders, 19 hours ago
[x]  

41 images for adap

WKRB News, 3 weeks ago
Mashable, 1 week ago
Ticker Report, 3 weeks ago
American Banking News, 3 weeks ago
Nasdaq, 3 weeks ago
American Banking News, 1 month ago
International Development Research Centre, 1 month ago
Freshnews.com, 1 month ago
Octafinance, 2 months ago
American Banking News, 1 month ago

Panama Motor Show Magazine

La revista (ADAP) es la primera revista digital interactiva sobre actualidad del mundo del motor en Panama. Conoce de forma interactiva las novedades que traen las marcas de automoviles cada mes, descubre las estadisticas de autos y marcas mas ...
 ZDNet3 weeks ago

Adaptimmune Therapeutics' (ADAP) CEO James Noble on Q3 2016 Results - Earnings Call Transcript

Adaptimmune Therapeutics plc (NASDAQ: ADAP ) Q3 2016 Earnings Conference Call November 10, 2016, 08:00 AM ET Executives Will Roberts - VP, IR James Noble - CEO Rafael Amado - Chief Medical Officer Adrian Rawcliffe - CFO Gwen ...
 Seeking Alpha3 weeks ago American Software's (AMSWA) CEO Mike Edenfield on Q2 2017 Results - Earnings Call Transcript  Seeking Alpha4 days ago American Software Reports Preliminary Second Quarter of Fiscal Year 2017 Results  SPi World News4 days ago AMERICAN SOFTWARE : Reports Preliminary Second Quarter of Fiscal Year 2017 Results  4 Traders4 days ago
[x]  

Adaptimmune reports Q3 results

aptimmune (NASDAQ:ADAP): Q3 EPADS of -$0.26 Revenue of $2.42M
 Seeking Alpha3 weeks ago

Adaptimmune, Merck to Test Cancer Drug (ADAP, MRK)

Adaptimmune Therapeutics and Merck are launching a joint cancer drug study to treat
 Yahoo! Finance1 month ago

Adaptimmune Puts Fludarabine Back On The Agenda

If Adaptimmune's (NASDAQ: ADAP ) only problem was the lack of responses in the first six patients enrolled into its ovarian cancer study of NY-ESO Spear then its 8% slide yesterday could easily be called an overreaction. However, the initial data ...
 Seeking Alpha1 month ago

Healthcare - Top 5 Gainers / Losers as of 11:00

Gainers: HTGM +69%. NSPR +31%. TRXC +8%. IPCI +6%. IDRA +6%. Losers: BSPM -17%. RXII -11%. ADAP -11%. TBPH -9%. XXII -7%. Now read: Biotech Forum Daily Digest: Better Times Ahead For Mylan? Revisiting The Investment Case On Aratana Therapeutics ...
 Seeking Alpha1 month ago

US Federal Business Opportunity: Department of the Navy: ADAP Lab Fiber Switches

Tags: News: Hardware Tenders:USA This was published: 13 Oct 2016 - 02:48 pm Tweet Agency: Department of the Navy Office: Naval Air Systems Command Location: NAVAIR HQ Date you need to respond by: 24-October-2016 Classification Code: 70 -- ...
 ITbriefing1 month ago
MySarawak

Penanggul putus bekal elektrik teputar enti projek TPTK 500kV tembu 2017

KUCHING: Penanggul putus bekal elekterik ke nyadi ba kandang adap ke selatan Sarawak kena Hari Enam enggau Hari Minggu tu tadi ulih diseliah enti Projek Talian Penghantaran Tunjang Kedua (TPTK) 500kV tembu ba suku kedua taun 2017. Menteri Perengka ...
 MySarawak1 week ago
WKRB News

Analysts Set Adaptimmune Therapeutics PLC (ADAP) Target Price at $15.50

Shares of Adaptimmune Therapeutics PLC (NASDAQ:ADAP) have been assigned an average recommendation of Buy from the eight research firms that are covering the company. Two research analysts have rated the stock with a sell rating and six have issued a ...
 Mideast Time1 week ago Adaptimmune Therapeutics PLC (ADAP) Given Consensus Recommendation of Buy by Analysts  American Banking News1 week ago Leerink Swann Reaffirms Buy Rating for Adaptimmune Therapeutics PLC (ADAP)  Zolmax News2 weeks ago Zacks Investment Research Lowers Adaptimmune Therapeutics PLC (ADAP) to Sell  American Banking News3 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less